CN117100818A - 一种治疗痔疮的外用膏剂及其制备方法 - Google Patents
一种治疗痔疮的外用膏剂及其制备方法 Download PDFInfo
- Publication number
- CN117100818A CN117100818A CN202311071747.1A CN202311071747A CN117100818A CN 117100818 A CN117100818 A CN 117100818A CN 202311071747 A CN202311071747 A CN 202311071747A CN 117100818 A CN117100818 A CN 117100818A
- Authority
- CN
- China
- Prior art keywords
- parts
- hemorrhoids
- traditional chinese
- treating
- hemorrhoid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000014617 hemorrhoid Diseases 0.000 title claims abstract description 104
- 239000002674 ointment Substances 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 239000000843 powder Substances 0.000 claims abstract description 21
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 15
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 15
- 241001313857 Bletilla striata Species 0.000 claims abstract description 15
- 229940037003 alum Drugs 0.000 claims abstract description 15
- 229940116229 borneol Drugs 0.000 claims abstract description 15
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 15
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229940126680 traditional chinese medicines Drugs 0.000 claims abstract description 15
- 229940105847 calamine Drugs 0.000 claims abstract description 14
- 229910052864 hemimorphite Inorganic materials 0.000 claims abstract description 14
- 235000014692 zinc oxide Nutrition 0.000 claims abstract description 14
- 239000011787 zinc oxide Substances 0.000 claims abstract description 14
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 claims abstract description 14
- 235000009388 Parthenocissus quinquefolia Nutrition 0.000 claims abstract description 11
- 241000219099 Parthenocissus quinquefolia Species 0.000 claims abstract 5
- 239000000203 mixture Substances 0.000 claims description 4
- 238000011282 treatment Methods 0.000 abstract description 24
- 238000000034 method Methods 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 15
- 239000003814 drug Substances 0.000 abstract description 9
- 210000004877 mucosa Anatomy 0.000 abstract description 7
- 230000008901 benefit Effects 0.000 abstract description 4
- 230000008569 process Effects 0.000 abstract description 4
- 239000011159 matrix material Substances 0.000 abstract description 3
- 230000000638 stimulation Effects 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 208000032843 Hemorrhage Diseases 0.000 description 24
- 208000002193 Pain Diseases 0.000 description 22
- 208000034158 bleeding Diseases 0.000 description 22
- 230000000740 bleeding effect Effects 0.000 description 22
- 230000036407 pain Effects 0.000 description 21
- 208000003251 Pruritus Diseases 0.000 description 18
- 210000000436 anus Anatomy 0.000 description 16
- 206010042674 Swelling Diseases 0.000 description 13
- 230000008961 swelling Effects 0.000 description 13
- 230000007803 itching Effects 0.000 description 12
- 230000013872 defecation Effects 0.000 description 11
- 238000002347 injection Methods 0.000 description 8
- 239000007924 injection Substances 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 241000563984 Ampelopsis Species 0.000 description 6
- 201000007772 internal hemorrhoid Diseases 0.000 description 6
- 235000013372 meat Nutrition 0.000 description 6
- 208000012287 Prolapse Diseases 0.000 description 5
- 210000002255 anal canal Anatomy 0.000 description 5
- 230000003179 granulation Effects 0.000 description 5
- 238000005469 granulation Methods 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 241000123835 Ampelopsis japonica Species 0.000 description 4
- 208000027744 congestion Diseases 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 208000035861 hematochezia Diseases 0.000 description 4
- 230000003902 lesion Effects 0.000 description 4
- 241000721047 Danaus plexippus Species 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 210000004400 mucous membrane Anatomy 0.000 description 3
- 230000002784 sclerotic effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- 208000016583 Anus disease Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010061213 Iatrogenic injury Diseases 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- 208000004550 Postoperative Pain Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 210000000664 rectum Anatomy 0.000 description 2
- 206010042772 syncope Diseases 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010002153 Anal fissure Diseases 0.000 description 1
- 206010068172 Anal pruritus Diseases 0.000 description 1
- 208000007860 Anus Neoplasms Diseases 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 208000009531 Fissure in Ano Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000032177 Intestinal Polyps Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 240000003433 Miscanthus floridulus Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033372 Pain and discomfort Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000031816 Pathologic Dilatation Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010036772 Proctalgia Diseases 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- 208000009544 Pruritus Ani Diseases 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 206010038084 Rectocele Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010040849 Skin fissures Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 210000003363 arteriovenous anastomosis Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 208000027503 bloody stool Diseases 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 210000004513 dentition Anatomy 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 210000000613 ear canal Anatomy 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010879 hemorrhoidectomy Methods 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000001969 hypertrophic effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 238000002504 lithotomy Methods 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 238000012148 non-surgical treatment Methods 0.000 description 1
- 230000008058 pain sensation Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000004848 polyfunctional curative Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 201000004240 prostatic hypertrophy Diseases 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 239000003229 sclerosing agent Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 210000004876 tela submucosa Anatomy 0.000 description 1
- 230000036346 tooth eruption Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 210000002073 venous valve Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Preparation (AREA)
- Zoology (AREA)
- Marine Sciences & Fisheries (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
Abstract
本发明公开了一种治疗痔疮的外用膏剂,由以下中药按照重量份配伍而成:煅炉甘石15‑30份、白芨6‑15份、白蔹5‑10份、珍珠粉0.5‑1份、枯矾1—2份、冰片0.5‑1份。1.本发明为纯中药制剂,无开刀手术,治疗过程及结果无创伤,无毒副作用。疗效确切,效果显著;2.本发明所用基质为水性凝胶,对患处皮肤粘膜无刺激;无油腻感,使皮肤感觉清爽,不污染衣物;3.便于携带,使用方便;4.价格低廉,社会效益好。
Description
技术领域
本发明涉及中药领域,具体为一种治疗痔疮的外用膏剂及其制备方法。
背景技术
痔疮,或者称痔,是临床上一种最常见的肛门疾病,英国人Thomson在1975年提出了痔的近代概念:痔是直肠下端的肛垫出现了病理性肥大。根据发生部位的不同,痔可分为内痔、外痔和混合痔。认为内痔(Internal hemorrhoid)是肛垫(肛管血管垫)的支持结构、血管丛及动静脉吻合支发生的病理性改变或移位。外痔(External hemorrhoid)是齿状线远侧皮下血管丛的病理性扩张或血栓形成。混合痔(Mixed hemorrhoid)是内痔和外痔混合体。
痔的具体发病机制尚未完全明确,可能与多种因素有关,目前主要有以下学说。
静脉曲张学说:静脉丛是形成肛垫的主要结构,痔的形成与静脉丛的病理性扩张、血栓形成有必然的联系。从解剖学上来看,门静脉系统及其分支直肠静脉都无静脉瓣;直肠上下静脉丛管壁薄、位置浅;末端直肠黏膜下组织松弛,这些因素都容易导致血液淤滞和静脉扩张。此外,由于直肠肛管位于腹腔最下部,多种因素,如长期的坐立、便秘、妊娠、前列腺肥大、盆腔巨大肿瘤等,均可引起直肠静脉回流受阻。目前颇有争议。
肛垫下移学说:肛垫起闭合肛管、节制排便作用。正常情况下,肛垫疏松地附着在肛管肌壁上;排便时受到向下的压力被推向下,排便后借助自身的收缩作用,缩回到肛管内。弹性回缩能力减弱后,肛垫则充血、下移形成痔。西医主流支持肛垫下移学说。
针对痔疮的情况,目前较为常见的治疗方法为:
1.透明帽辅助内镜下硬化术:治疗痔疮和粘膜脱垂是在2015年报道的一种新技术[9],是对传统硬化注射疗法的创新,是一种方便、安全、高效的内镜下微创治疗痔疮的新方法,作为消化内镜医师治疗痔疮和黏膜脱垂等肛直肠病变的新选择。CAES是非手术疗法中最有效的选择,特别适合有出血风险的患者。然而,传统的硬化注射治疗是由医师通过肛门镜进行操作,因为其最大的并发症是注射位置错误导致的医源性损伤,CAES有助于避免这一问题。CAES技术的核心在于,利用透明帽辅助肠镜,在充气的条件下,充分暴露肛直肠病变,顺镜条件下操作,然后利用一根可以从肠镜钳道孔伸出来的长针(注:不是常用的4mm长的粘膜下注射针,而是至少10mm长),在齿状线上方进针,直视下向痔疮基底部注射硬化剂,边注射边退针,推荐注射结束后停止至少5秒拔针,注射点一般不出血,术后无疼痛不适。无痛肠镜下有助于肛门松弛。该法的特殊之处在于,避免传统硬化术的医源性损伤,整个硬化治疗过程就好比在每一个需要治疗的地方都打上一条“硬化柱”。这种新方法主要适合用于治疗痔疮Ⅰ度、Ⅱ度、部分Ⅲ度,直肠黏膜脱垂,内镜下切除肛门赘生物和瘤性病变前的基底部预防出血治疗。尤其对于全身状态差,合并难以控制的痔疮出血,也不具有外科手术条件的患者,CAES则凸显了风险低、方便、有效的优点。完整的肠道准备和肠镜检查,则适合一并实施肠镜诊断、肠道息肉切除、CAES等目的。CAES解决的不只是控制痔疮出血,更重要的在于在后期实现肛垫上移的目的。如果有准备的组织,肠镜检查基础上,开展CAES及相关肠镜下诊疗,患者的医疗花费将会大幅节省。
2.胶圈套扎疗法:用于治疗Ⅰ-Ⅲ度内痔患者。胶圈套扎的原理是将胶圈套入到内痔的根部,利用胶圈弹性阻断痔的血运,从而使痔块发生缺血、坏死、脱落而愈合。注意套扎位置的选择,不能套在齿状线及皮肤上,避免引起剧烈疼痛。特点是费用较高。
3.超声多普勒引导下痔动脉结扎术:用于治疗Ⅱ-Ⅳ度内痔患者。其原理是利用一种特制的带有多普勒超声探头的直肠镜,探测到位于齿状线上方的动脉后直接进行结扎,从而阻断痔的血运而达到治疗目的。术后疼痛是突出特点。进一步的干预治疗方法还包括痔单纯切除术、吻合器痔上黏膜环切术、血栓外痔剥离术等。
4.痔单纯切除术:用于治疗Ⅱ、Ⅲ度内痔和混合痔患者。患者取侧卧位、截石位或俯卧位,麻醉后进行痔核切除。嵌顿痔也可以采用这种方法进行急诊切除。术后疼痛是突出特点。
5.吻合器痔上黏膜环切术:临床上通用名称为PPH(Procedure for prolapse andhemorrhoids)手术,主要用于治疗Ⅲ、Ⅳ度内痔、非手术治疗失败的Ⅱ度内痔和环状痔患者,也可用于治疗直肠黏膜脱垂患者。其原理是利用专门设计的吻合器环行切除距离齿状线2cm以上的直肠黏膜2-4cm,从而使下移的肛垫上移固定而达到治疗目的。特点是器械花费较高。
总之:目前痔的治疗方法很多,在健康教育、饮食管理、排便习惯训练基础上,以非手术治疗为主,其中注射疗法(特别是CAES)对大部分患者具有良好的治疗效果。非手术治疗失败或者不适宜非手术治疗的患者可以选择手术治疗。手术方法会造成术后创伤,有些患者不适应。儿上述提供的多种非手术方法多周期长,且可以作为日常痔疮防治效果更好。
因此,提供一种能够快速治疗痔疮,且不会造成创伤的治疗痔疮的外用膏剂及其制备方法。
发明内容
为了解决上述现有技术中存在的不足,本发明提供了一种治疗痔疮的外用膏剂及其制备方法。
本发明的目的是这样实现的:
一种治疗痔疮的外用膏剂,其特征在于,由以下中药按照重量份配伍而成:
煅炉甘石15-30份 白芨6-15份 白蔹5-10份
珍珠粉0.5-1份 枯矾1—2份 冰片0.5-1份
一种治疗痔疮的外用膏剂,其特征在于,由以下中药按照重量份配伍而成:
煅炉甘石15份 白芨6份 白蔹5份
珍珠粉0.5份 枯矾1份 冰片0.5份
一种治疗痔疮的外用膏剂,其特征在于,由以下中药按照重量份配伍而成:
煅炉甘石30份 白芨15份 白蔹10份
珍珠粉1份 枯矾2份 冰片1份
一种治疗痔疮的外用膏剂,其特征在于,由以下中药按照重量份配伍而成:
煅炉甘石20份 白芨12份 白蔹8份
珍珠粉0.8份 枯矾1.5份 冰片0.7份
一种治疗痔疮的外用膏剂的制备方法为: 上述组方按重量份数比例各药粉碎成极细粉,混合均匀加入至熔化后的水性凝胶中,搅拌均匀冷却至室温,灌装即得。
积极有益效果:1.本发明为纯中药制剂,无开刀手术,治疗过程及结果无创伤,无毒副作用。疗效确切,效果显著;2.本发明所用基质为水性凝胶,对患处皮肤粘膜无刺激;无油腻感,使皮肤感觉清爽,不污染衣物;3.便于携带,使用方便;4.价格低廉,社会效益好。
实施方式
下面结合具体实施方式,对本发明做进一步的说明:
一种治疗痔疮的外用膏剂,其特征在于,由以下中药按照重量份配伍而成:
煅炉甘石15-30份 白芨6-15份 白蔹5-10份
珍珠粉0.5-1份 枯矾1—2份 冰片0.5-1份
一种治疗痔疮的外用膏剂,其特征在于,由以下中药按照重量份配伍而成:
煅炉甘石15份 白芨6份 白蔹5份
珍珠粉0.5份 枯矾1份 冰片0.5份
一种治疗痔疮的外用膏剂,其特征在于,由以下中药按照重量份配伍而成:
煅炉甘石30份 白芨15份 白蔹10份
珍珠粉1份 枯矾2份 冰片1份
一种治疗痔疮的外用膏剂,其特征在于,由以下中药按照重量份配伍而成:
煅炉甘石20份 白芨12份 白蔹8份
珍珠粉0.8份 枯矾1.5份 冰片0.7份
一种治疗痔疮的外用膏剂的制备方法为: 上述组方按重量份数比例各药粉碎成极细粉,混合均匀加入至熔化后的水性凝胶中,搅拌均匀冷却至室温,灌装即得。
本发明配方按君、臣、佐、使的中药配伍原则组合而成;其中:煅炉甘石性味甘、平,具有解毒、收湿、止痒、敛疮之功效。用于湿热瘀阻所致的各类痔疮、湿疹等。在配方中是为君药。
白芨、白蔹为臣药。白芨性味苦、甘、涩,微寒。具有收敛止血、消肿生肌之功效。用于湿疮瘙痒、咯血、吐血,疮疡肿毒,皮肤皲裂。
白蔹性味苦、微寒。具有清热解毒,消痛散结,敛疮生肌之功效。用于痈疽发背,疔疮,瘰疠,烧烫伤等。
枯矾、珍珠粉、冰片为左使之药。协同主药物共同发挥清热燥湿,活血消肿,去腐生肌之功效。其中枯矾性味酸、涩、寒。外用解毒杀虫,燥湿止痒,收湿敛疮,止血化腐;用于湿疹,疥癣,脱肛痔疮等证。
珍珠粉性味甘、咸、寒,具有安神定惊,明目消翳,解毒生肌,润肤祛斑之功效,用于惊悸失眠,惊风癫痫,目赤翳障。
冰片辛、苦、微寒。具有开窍醒神,清热止痛之功效。用于热病神昏、惊厥,中风痰厥,气郁暴厥,中恶昏迷。胸痹心痛,目赤,口疮,咽喉肿痛,耳道流脓等症。
以上各药通过按照君、臣、佐、使之配伍原则共同组成具有清热燥湿,活血消肿解毒、祛腐、收敛生肌之功效的一种治疗各种痔疮的良方。用于治疗因湿热瘀阻所致的各类痔疮、肛裂,症见大便出血或红肿热痛,或肛周湿疹瘙痒等。
病例一:张广勇 男 38岁 永城市裴桥镇万楼村人。职业货车司机,于2018年5月26日来万仁堂诊所就诊,自述肛周肿胀,稍感疼痛,已有月余。经检查其肛门齿状线下,能触及至硬物。诊断为外痔。经用本膏剂治疗一周后复诊,症状基本消失,随又经一周治疗后,随访患者已康复。
病例二:闻希胜 男 28岁 永城市芒山镇李楼村人,某公司会计。于2020年3月18日来万仁堂诊所就诊。自述大便后带血,疼痛,已有月余。经检查,在肛门齿状线以上,病灶为直肠粘膜所覆盖。诊断为内痔。随用膏剂治疗。一周后复诊,患者自述大便后出血减少,疼痛减轻。又用膏剂继续治疗一周。经随访患者自述大便后不见出血,疼痛消失,已基本康复。
病例三:杜明周 男35岁 砀山县乔楼村人 永城市某公司员工。2020年8月2日来万仁堂诊所就诊。自述近月余大便后有少量出血,肛门部疼痛剧烈。经检查,肛门部齿状线上下能触及到硬物。诊断为混合痔。随用本膏剂治疗一周后复诊,肛门部硬物缩小,疼痛减轻,继续用本膏剂治疗二周后随访其症状基本消失,又用药一周巩固治疗。
病例四
秦三妮,女,56岁
内外痔8年,肛门瘙痒,肛门部大便出血,色鲜红,便后有异物突出,不能自行还纳。在药房购买痔疮膏使用第一天只有清凉感觉,第二天瘙痒只减轻一点,第三天只感觉肛门有稍微清凉干,出血,肿胀等症状并未减轻。经推荐使用痔疮凝胶。第一天,肛门外3点处可见肿物脱出,最大约0.8*0.9cm大小左右,痔核充血严重,瘙痒肿胀疼痛,排便伴随出血,如厕疼痛。用痔疮凝胶涂抹外部并将注入管轻轻推入肛门内,挤入4克药膏,一天2次。第二天,骚症状减轻一半,痔核肿胀减轻,流血减少,痔核充血情况减少。并按照首次用法一天2次。第三天,不再瘙痒,排便不再出血,排便疼痛感减轻,明显看到痔核肿胀减小,按照首次用法一天2次。第四天,痔核不再出血,排便没有疼痛感,能轻松排便,按照首次用法一天2次。给患者痔疮凝胶自己每天涂抹2次并挤入4克药膏,每4天复诊一次,25天之后痊愈,没有瘙痒,出血症状,肿胀已消除,排便没有疼痛感,痔疮肉球肉眼可见明显缩小至肛周内。
病例五:
王涛阳,男,36岁,
痔疮5年,属于外痔,上厕所感觉有肉球脱出,檫屁股有撕裂痛觉,平时坐凳子有瘙痒感觉,反复出血并便血。自己购买痔疮喷雾一天喷4次,第一天喷完有清凉感觉,骚扰减轻,第二天偶尔瘙痒,第三天只感觉肛门清凉干,但出血,肿胀等症状并未减轻。用完1盒之后没有再使用,转经熟人介绍到我站购买使用痔疮凝胶。第一天,肛门外4点处可见肿物脱出,约1.1*0.9cm大小左右,瘙痒红肿,痔核充血严重,便血严重,如厕伴随疼痛。用痔疮凝胶涂抹外部,一天3次。第二天不再有瘙痒感觉,肛周比较清爽干燥,痔核流血减少,痔核充血情况减少,按照首次用法,一天3次。第三天痔核少量血丝,大便不再出血,红肿已消痛,完全没有瘙痒感觉。按照首次用法,一天3次。第四天痔核颜色逐渐变竭,排便不再出血,没有疼痛刺痛感,上厕所肉球脱出情况明显减少。给患者痔疮凝胶自己每天涂抹3次,每4天复诊一次,23天之后痊愈,没有出血症状,排便没有疼痛感,上厕所不再有肉球脱出情况,痔疮肉球萎缩。
病例六:
荆俊芳,女,72岁,
大便有物脱出、出血6年,加重2天,出现肛门部大便出血,色鲜红肿胀,每次约3ml,排便刺痛难受并伴随瘙痒,属于内痔严重。去诊所购买痔疮凝胶,第一天用完骚扰减轻,便血情况严重,第二天不再瘙痒,肛周疼痛感减弱,便血情况有一点减轻,第三天只感觉肛门清凉干,但出血情况稍微减轻。经介绍到我站使用痔疮凝胶。第一天,刺痛感减轻,出血量减少到1.5ml 左右。用痔疮凝胶涂抹肛周外部并将注入管轻轻推入肛门内,挤入4克药膏,一天3次。第二天,不再有瘙痒感觉,排便只有轻微疼痛感,排便稍微有红血丝。并按照首次用法一天3次。第三天,排便已没有疼痛感和瘙痒,红肿已缓解,颜色变竭,排便不再出血,肉球萎缩。给患者痔疮凝胶自己每天涂抹3次,每3天复诊一次,24天之后痊愈,红肿全部消退,瘙痒已消失,不再出血,排便没有刺痛感,肛周已变成竭色。
1.本发明为纯中药制剂,无开刀手术,治疗过程及结果无创伤,无毒副作用。疗效确切,效果显著;2.本发明所用基质为水性凝胶,对患处皮肤粘膜无刺激;无油腻感,使皮肤感觉清爽,不污染衣物;3.便于携带,使用方便;4.价格低廉,社会效益好。
Claims (5)
1.一种治疗痔疮的外用膏剂,其特征在于,由以下中药按照重量份配伍而成:煅炉甘石15-30份 白芨6-15份 白蔹5-10份 珍珠粉0.5-1份 枯矾1—2份 冰片0.5-1份。
2.根据权利要求1所述的一种治疗痔疮的外用膏剂,其特征在于,由以下中药按照重量份配伍而成:煅炉甘石15份 白芨6份 白蔹5份 珍珠粉0.5份 枯矾1份 冰片0.5份 。
3.根据权利要求1所述的一种治疗痔疮的外用膏剂,其特征在于,由以下中药按照重量份配伍而成:煅炉甘石30份 白芨15份 白蔹10份 珍珠粉1份 枯矾2份 冰片1份 。
4.根据权利要求1所述的一种治疗痔疮的外用膏剂,其特征在于,由以下中药按照重量份配伍而成:煅炉甘石20份 白芨12份 白蔹8份 珍珠粉0.8份 枯矾1.5份 冰片0.7份 。
5.如权利要求1-4所述的一种治疗痔疮的外用膏剂的制备方法为: 上述组方按重量份数比例各药粉碎成极细粉,混合均匀加入至熔化后的水性凝胶中,搅拌均匀冷却至室温,灌装即得。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311071747.1A CN117100818A (zh) | 2023-08-24 | 2023-08-24 | 一种治疗痔疮的外用膏剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311071747.1A CN117100818A (zh) | 2023-08-24 | 2023-08-24 | 一种治疗痔疮的外用膏剂及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117100818A true CN117100818A (zh) | 2023-11-24 |
Family
ID=88801546
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311071747.1A Pending CN117100818A (zh) | 2023-08-24 | 2023-08-24 | 一种治疗痔疮的外用膏剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117100818A (zh) |
-
2023
- 2023-08-24 CN CN202311071747.1A patent/CN117100818A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108992488A (zh) | 一种治疗慢性鼻炎的中药及制备方法 | |
CN102078391A (zh) | 一种治疗颈肩腰腿疼痛的药物 | |
CN111529592A (zh) | 一种防治痔的中药组合物及其制备方法 | |
BR112021001873A2 (pt) | composição para o uso na prevenção e/ou tratamento da mucosa genitourinária | |
RU2318503C1 (ru) | Способ лечения анальной трещины | |
CN117100818A (zh) | 一种治疗痔疮的外用膏剂及其制备方法 | |
CN109745451A (zh) | 一种治疗痔疮的药剂及其制备方法 | |
US20070078417A1 (en) | Method and system for systematically treating hemorrhoids | |
Shah et al. | Efficacy of Kshara application in the management of internal haemorrhoids–A pilot study | |
WO2022011881A1 (zh) | 一种用于预防和治疗痔疮的药物及其应用 | |
CN102218118B (zh) | 一种治疗肛裂的药膏及其制备方法 | |
CN107080762B (zh) | 地梢瓜作为治疗痔疮的药物的应用 | |
Filingeri et al. | Beneficial effects of Flavonoids after ambulatory therapy with Combined Hemorrhoidal Radiocoagulation (CHR). | |
CN110882313B (zh) | 一种治疗月经不调、急慢性盆腔炎和宫颈炎的药物及其应用 | |
RU2080869C1 (ru) | Способ лечения заболеваний натуральными соками лекарственных растений | |
CN105477015A (zh) | 一种用于肛瘘术后的外用中药洗剂及其制备方法 | |
CN102920854B (zh) | 一种治疗痔瘘的中药注射液 | |
Porwal et al. | A Comparative Clinical Study of Anoac Cream with Marketed Ointment in patients with Haemorrhoids, Fissures and Fistulas | |
CN111494490A (zh) | 痔疮垫的中草药组合物及其制备方法 | |
CN106924369A (zh) | 一种用于治疗痔疮的维吾尔药组合物及其生产方法 | |
CN109876091A (zh) | 治疗胆道系结石和泌尿系统结石的中药组合物及制备方法 | |
CN118078896A (zh) | 一种辅助治疗内痔的中药熏洗剂 | |
CN115006458A (zh) | 一种腱弓方方剂 | |
Lamina et al. | Shortwave diathermy in the management of chronic pelvic inflammatory disease pain | |
CN114053286A (zh) | 一种药物组合物及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication |